Current Attitudes toward Unfunded Cancer Therapies among Canadian Medical Oncologists
暂无分享,去创建一个
[1] M. Trudeau,et al. Pan-Canadian Oncology Drug Review (pCODR): A unique model to support harmonization of cancer drug funding decisions in Canada. , 2018, Journal of Clinical Oncology.
[2] Kelvin K. W. Chan,et al. The economic burden of cancer care in Canada: a population-based cost study. , 2018, CMAJ open.
[3] M. Stockler,et al. Discussing and prescribing expensive unfunded anticancer drugs in Australia , 2017, ESMO Open.
[4] J. Peppercorn,et al. Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care. , 2016, Journal of oncology practice.
[5] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[6] M. Mamdani,et al. Overcoming obstacles in accessing unfunded oral chemotherapy: physician experience and challenges. , 2013, Journal of oncology practice.
[7] J. Mellor,et al. Access to anticancer drugs: many evidence‐based treatments are off‐label and unfunded by the Pharmaceutical Benefits Scheme , 2012, Internal medicine journal.
[8] Kelvin K. W. Chan,et al. Less than ideal: how oncologists practice with limited drug access. , 2012, Journal of oncology practice.
[9] C. Bell,et al. Variation and consternation: access to unfunded cancer drugs in Canada. , 2012, Journal of oncology practice.
[10] L. Fallowfield,et al. The views of patients and the general public about expensive anti-cancer drugs in the NHS: a questionnaire-based study , 2011, JRSM short reports.
[11] A. Culyer,et al. Access to cancer drugs in Canada: looking beyond coverage decisions. , 2011, Healthcare policy = Politiques de sante.
[12] J. Savulescu,et al. To tell or not to tell: the community wants to know about expensive anticancer drugs as a potential treatment option. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] Douglas K. Martin,et al. The effect of priority setting decisions for new cancer drugs on medical oncologists' practice in Ontario: a qualitative study , 2007, BMC Health Services Research.
[14] D. Schrag,et al. Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] J. Savulescu,et al. Do oncologists discuss expensive anti-cancer drugs with their patients? , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.